Semaglutide remains under patent protection, so there are only brand-name versions (Ozempic, Wegovy, and Rybelsus) available. If youre uninsured, or your health insurance provider doesnt provide coverage for this injectable medicine, there are other ways you may lower your costs
The speed of the development pipeline only adds to the challenge as GLP1 therapies are being used for approved indications beyond diabetes and obesity, including heart, liver and renal disease. With these evolving usage patterns, plan sponsors face a coverage dilemma defined by constant change and escalating financial exposure
Opinion- drugs versus life style modification The lack of success in controlling obesity has begged the questions, as a society
Duration is individualized
In our study using June 2024 data on fee-for-service Medicaid in 50 states and Washington, D.C., only 13 covered GLP-1s for weight loss in adults